Home/Filings/4/0000950170-24-037389
4//SEC Filing

Violette Shelia M. 4

Accession 0000950170-24-037389

CIK 0001661998other

Filed

Mar 26, 8:00 PM ET

Accepted

Mar 27, 5:36 PM ET

Size

5.4 KB

Accession

0000950170-24-037389

Insider Transaction Report

Form 4
Period: 2024-03-25
Violette Shelia M.
Chief Scientific Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-25+56,41356,413 total
    Exercise: $16.82Exp: 2034-03-24Common Stock (56,413 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Documents

1 file

Issuer

Q32 Bio Inc.

CIK 0001661998

Entity typeother

Related Parties

1
  • filerCIK 0002016144

Filing Metadata

Form type
4
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:36 PM ET
Size
5.4 KB